Business Context and Reporting Period
This Form 8-K was filed by Second Sight Medical Products, Inc. on July 6, 2016. The filing addresses a proposed rule by the Centers for Medicare & Medicaid Services (CMS) regarding the 2017 Medicare Hospital Outpatient Prospective Payment System. The company's principal product mentioned is the Argus II retinal prosthesis system.
Key Financial Metrics
The filing does not provide standard financial metrics such as revenue, profit, cash flow, margins, debt, or liquidity. Instead, it reports specific proposed reimbursement rates:
- 2016 Medicare Payment Rate: Approximately $95,000 for the Argus II and associated surgical implantation (CPT 0100T under APC 1599).
- Proposed 2017 Medicare Payment Rate: Approximately $150,000 for the Argus II and associated surgical implantation (New Technology APC 1906).
Material Changes Versus Prior Period
CMS has proposed reassigning the procedure code CPT 0100T from APC 1599 to a new technology category, APC 1906. This change represents a proposed increase in the Medicare hospital outpatient rate from approximately $95,000 in 2016 to approximately $150,000 for calendar year 2017. This adjustment is based on stakeholder comments, procedural learning, and a review of 2015 hospital claims data.
Guidance, Outlook, and Risks
Scope of Impact: The proposed rule affects Medicare payments to hospitals under the Outpatient Prospective Payment System and Ambulatory Surgical Center (ASC) Payment System. It does not directly alter payments from Medicare Advantage, private U.S. health insurance, or non-U.S. business.
Contingencies and Risks: This is a proposed rule published for public comment. The filing explicitly states that no assurance can be made that the final rule will not differ substantially from the proposed rule.
Investor Verification Checklist
- Verify the final CMS rule for 2017 to confirm if the proposed $150,000 rate is adopted.
- Assess the impact of the rate change on hospital adoption rates of the Argus II system.
- Monitor the public comment period outcome and any subsequent revisions to the proposed APC 1906 classification.
- Review future filings for updates on reimbursement rates from private insurers and Medicare Advantage, which are not covered by this specific proposal.